ABSTRACT
Dear Editor, Granuloma annulare (GA) is an inflammatory skin disease that has been associated with diabetes, dyslipidaemia, hypothyroidism and autoimmune disorders.1,2 The annualized incidence and prevalence of GA in the USA are approximately 0.04% and 0.06%, respectively (with a female predominance).3 GA is clinically classified as localized (75% of cases), generalized or subcutaneous.4 There is a body of evidence supporting an association between several inflammatory dermatoses, such as psoriasis, and mental health conditions.5 Improvement of depression and anxiety following treatment of certain inflammatory dermatoses has also been described.5 It has been postulated that this association may, in part, relate to proinflammatory cytokines, which have been proposed to mechanistically connect inflammatory dermatoses and mental health conditions.6 A recent nested case-control study demonstrated a significant association of GA with depression, insomnia, opioid dependence and post-traumatic stress disorder.7 This study aims to investigate whether an association exists between GA and anxiety.
Subject(s)
Granuloma Annulare , Psoriasis , United States/epidemiology , Humans , Female , Male , Granuloma Annulare/complications , Granuloma Annulare/epidemiology , Case-Control Studies , Psoriasis/complications , Anxiety/epidemiology , National Institutes of Health (U.S.)ABSTRACT
BACKGROUND: Granuloma annulare (GA) is a benign granulomatous skin disorder that is generalized (GGA) in 15 % of cases. Although many case reports describe a relationship between GGA and systemic diseases, few large series have been published, and their association is debated. We present herein a series of GGA in order to describe their clinical and histological features. PATIENTS AND METHODS: We included all biopsy-proven cases of GA presenting at the dermatopathology laboratory of Strasbourg where generalized (i.e. over 10 lesions). Clinical features were obtained from patients' medical files. RESULTS: We included 35 GGA, with a sex ratio of 0.5. The mean age was 54 years. Lesions were annular or non-annular in equal measure and were symptomatic in 25 % of cases. Most patients (77 %) had an associated disease, already known in 60 % of cases, including dyslipidemia (27 %), diabetes mellitus (20 %), immunosuppressive drugs (17 %), atopy (17 %), auto-immune disease (17 %), hematological disease (14 %), and cancer (9 %). Histological analysis revealed the predominant pattern to be interstitial (54 %) rather than palisading (20 %), having no correlation with clinical type. Eosinophils were frequent (46 %) in GA but were not correlated with systemic disease or drug taking. Among the 40 % of patients treated, 50 % had a successful outcome on topical corticosteroids, doxycycline, antimalarial drugs or phototherapy. DISCUSSION: GGA differs from localized GA, which is mostly associated with an already known systemic disease, whether metabolic, infectious or neoplastic, uncorrelated with clinical or histological features, and screening is necessary.
Subject(s)
Granuloma Annulare/pathology , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Aged, 80 and over , Antimalarials/therapeutic use , Autoimmune Diseases/epidemiology , Child , Child, Preschool , Comorbidity , Diabetes Mellitus/epidemiology , Doxycycline/therapeutic use , Dyslipidemias/epidemiology , Female , France/epidemiology , Granuloma Annulare/drug therapy , Granuloma Annulare/epidemiology , Granuloma Annulare/therapy , Humans , Hypersensitivity, Immediate/epidemiology , Immunosuppression Therapy/adverse effects , Male , Middle Aged , Neoplasms/epidemiology , Phototherapy , Retrospective Studies , Young AdultSubject(s)
Granuloma Annulare , Population Health , Humans , Granuloma Annulare/epidemiology , Case-Control Studies , ComorbidityABSTRACT
BACKGROUND: Granuloma annulare (GA) is a granulomatous skin eruption rarely associated with cancer. We report seven cases of paraneoplastic GA in association with solid organ malignancy. OBJECTIVE: To compare the clinical and histopathological features of paraneoplastic GA to case-matched controls of classic GA. METHODS: Retrospective chart and histopathological review of 7 individuals and 13 age- and sex-matched controls. Paraneoplastic GA was defined as GA occurring within 6 months of the diagnosis of solid organ malignancy and/or persistent GA that resolved with cancer treatment. RESULTS: Most cases of paraneoplastic GA were associated with lung cancer (4/7). The clinical and histopathological features of paraneoplastic and classic GA were similar. Compared to classic GA, paraneoplastic GA cases were more often generalized disease (6/7 vs 6/13), refractory to treatment, and had a perivascular inflammatory cell infiltrate (5/7 vs 2/13). All cases of paraneoplastic GA that underwent definitive treatment of their cancer improved. LIMITATIONS: Single-institution, retrospective review with a small sample size. CONCLUSION: Paraneoplastic GA is rare, similar to classic GA, and refractory to treatment. We advocate for age-appropriate screening in individuals with GA that is nonresponsive to multiple lines of systemic treatment and evaluating patients with concerning signs or symptoms for an underlying neoplasm.
Subject(s)
Cell Transformation, Neoplastic/pathology , Granuloma Annulare/epidemiology , Granuloma Annulare/pathology , Lung Neoplasms/epidemiology , Paraneoplastic Syndromes/pathology , Aged , Brain Neoplasms/epidemiology , Brain Neoplasms/pathology , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Case-Control Studies , Female , Glioblastoma/epidemiology , Glioblastoma/pathology , Glioblastoma/therapy , Humans , Incidence , Lung Neoplasms/pathology , Male , Melanoma/epidemiology , Melanoma/pathology , Melanoma/therapy , Middle Aged , Paraneoplastic Syndromes/epidemiology , Prognosis , Risk Assessment , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology , Treatment OutcomeABSTRACT
Granuloma annulare (GA) is a poorly understood condition characterized by a set of clinical morphologic variants with 2 predominant histopathologic patterns of inflammation. This review provides a comprehensive overview of the available information about the clinical variants and histopathologic features, current epidemiologic data, and potential genetic underpinnings of GA. Much of the current understanding of GA is based on retrospective studies, case series, and case reports; this review aims to synthesize the available information and present it clearly for practicing dermatologists.
Subject(s)
Granuloma Annulare , Granuloma Annulare/epidemiology , Granuloma Annulare/genetics , Granuloma Annulare/pathology , HumansABSTRACT
INTRODUCTION AND OBJECTIVES: Necrobiosis lipoidica (NL) is a chronic idiopathic granulomatous disease considered to occur in association with diabetes mellitus. Data on the frequency of this association, however, are inconsistent. Our aim was to retrospectively analyze the clinical characteristics of patients diagnosed with NL at our hospital and to investigate the association with diabetes mellitus and other diseases. MATERIAL AND METHODS: We performed a chart review of all patients with a clinical and histologic diagnosis of NL treated and followed in the dermatology department of Hospital de Bellvitge in Barcelona, Spain between 1987 and 2013. RESULTS: Thirty-five patients (6 men and 29 women with a mean age of 47.20 years) were diagnosed with NL in the study period. At the time of diagnosis, 31 patients had pretibial lesions. Thirteen patients (37%) had a single lesion at diagnosis, and the mean number of lesions was 3.37. Twenty-three patients (65.71%) had diabetes mellitus (type 1 in 10 cases and type 2 in 13). In 20 patients, onset of diabetes preceded that of NL by a mean of 135.70 months. The 2 conditions were diagnosed simultaneously in 3 patients. None of the 35 patients developed diabetes mellitus during follow-up. Six patients had hypothyroidism, and 4 of these also had type 1 diabetes. CONCLUSIONS: NL is frequently associated with type 1 and 2 diabetes. Although diabetes tends to develop before NL, it can occur simultaneously.
Subject(s)
Diabetes Mellitus, Type 1/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Necrobiosis Lipoidica/epidemiology , Adolescent , Adult , Aged , Comorbidity , Female , Granuloma Annulare/epidemiology , Humans , Hypothyroidism/epidemiology , Leg Ulcer/etiology , Male , Middle Aged , Necrobiosis Lipoidica/complications , Telangiectasis/etiologySubject(s)
Granuloma Annulare/epidemiology , Granuloma Annulare/pathology , Neoplasms/epidemiology , Neoplasms/pathology , Aged , Aged, 80 and over , Case-Control Studies , Comorbidity , Databases, Factual , Female , Humans , Male , Middle Aged , Neoplasm Invasiveness/pathology , Neoplasm Staging , Prevalence , Reference Values , Spain/epidemiologySubject(s)
Cell Transformation, Neoplastic/pathology , Granuloma Annulare/epidemiology , Granuloma Annulare/pathology , Neoplasms/epidemiology , Neoplasms/pathology , Age Factors , Aged , Comorbidity , Female , Granuloma Annulare/diagnosis , Humans , Incidence , Male , Middle Aged , Neoplasms/diagnosis , Prognosis , Risk Assessment , Sex FactorsABSTRACT
This paper will give a comprehensive view of the most frequent panniculitides seen in childhood, with emphasis on the types exclusively found in infancy, and for all other types of panniculitides also found in adults. Aim of this paper is also to analyze the clinical differences between panniculitis in childhood and in adulthood, and to give reliable histopathologic criteria for a specific diagnosis. A review of the literature is here integrated by authors' personal contribution. Panniculitides in children is a heterogeneous group of diseases, as well as in adult life, characterized by inflammation of the subcutaneous fat. Only very few types of panniculitis are exclusively found in childhood, such as Sclerema neonatorum and subcutaneous fat necrosis of the newborn, while the vast majority of the other types may be found both in paediatric age and in adults. Furthermore, this paper will consider in detail panniculitis according to their frequency, such as Erythema nodosum, Lupus panniculitis, Cold panniculitis, panniculitis in Behçet disease, and poststeroid panniculitis. It will also describe rare forms of panniculitis, such as Eosinophilic panniculitis (a pathological entity debated by many authors), Subcutaneous panniculitis T-cell lymphoma, and the different forms of the so call "Lipophagic panniculitis", encompassing respectively the febrile relapsing panniculitis of Weber-Christian disease and the non-relapsing form of Rothmann-Makai disease. For each type of panniculitis considered concise information will be given about epidemiology, etiology, clinical findings, laboratory data, prognosis and therapy, while histopathologic findings will be described in detail.
Subject(s)
Panniculitis/pathology , Adrenal Cortex Hormones/adverse effects , Age of Onset , Behcet Syndrome/complications , Cellulitis/blood , Cellulitis/epidemiology , Cellulitis/pathology , Cellulitis/therapy , Child , Child, Preschool , Cold Temperature/adverse effects , Diagnosis, Differential , Eosinophilia/blood , Eosinophilia/epidemiology , Eosinophilia/pathology , Eosinophilia/therapy , Erythema Nodosum/blood , Erythema Nodosum/diagnosis , Erythema Nodosum/epidemiology , Erythema Nodosum/pathology , Erythema Nodosum/therapy , Fat Necrosis/blood , Fat Necrosis/epidemiology , Fat Necrosis/pathology , Fat Necrosis/therapy , Granuloma Annulare/blood , Granuloma Annulare/epidemiology , Granuloma Annulare/pathology , Granuloma Annulare/therapy , Humans , Infant , Infant, Newborn , Lymphoma, T-Cell, Cutaneous/blood , Lymphoma, T-Cell, Cutaneous/epidemiology , Lymphoma, T-Cell, Cutaneous/pathology , Lymphoma, T-Cell, Cutaneous/therapy , Panniculitis/classification , Panniculitis/diagnosis , Panniculitis/epidemiology , Panniculitis/etiology , Panniculitis/therapy , Panniculitis, Nodular Nonsuppurative/blood , Panniculitis, Nodular Nonsuppurative/epidemiology , Panniculitis, Nodular Nonsuppurative/pathology , Panniculitis, Nodular Nonsuppurative/therapy , Sclerema Neonatorum/blood , Sclerema Neonatorum/epidemiology , Sclerema Neonatorum/pathology , Sclerema Neonatorum/therapy , Subcutaneous Fat/pathology , alpha 1-Antitrypsin Deficiency/complicationsABSTRACT
Granuloma annulare (GA) is a cutaneous inflammatory disorder of unknown cause, typically characterized by an annular arrangement of dermal papules and nodules. While GA in adults has been linked to diabetes mellitus (DM) and other conditions, these associations have been less studied in children. A retrospective chart review was conducted of all pediatric patients diagnosed with GA at an urban academic institution over a 7-year period. A total of 47 patients were reviewed. Of these, 41 (85.1%) patients had localized GA, 3 (6.38%) had subcutaneous GA, 2 (4.26%) had generalized GA, and 1 (2.13%) had both localized and subcutaneous GA. The extremities were the most common site of involvement across all morphologies. Atopic conditions were determined in 23 (48.9%) patients, 16 (34.0%) of which had asthma, either alone or in conjunction with atopic dermatitis or allergic rhinitis. None of the patients carried a diagnosis of DM, and all 11 patients who were tested within 3 years of the documented visit had normal results. In summary, this retrospective series characterizes the presentation of pediatric GA and highlights a potential association with atopy. An association with DM was not observed.
Subject(s)
Diabetes Mellitus , Granuloma Annulare , Adult , Child , Comorbidity , Granuloma Annulare/diagnosis , Granuloma Annulare/epidemiology , Humans , Retrospective Studies , SkinABSTRACT
Granuloma annulare (GA) is an inflammatory granulomatous skin disease that can be localized (localized GA) or disseminated (generalized GA), with patch, perforating, and subcutaneous subtypes being less common variants of this benign condition. Recently, new research has emerged that further elucidates GA epidemiology and etiopathogenesis; importantly, new therapeutic options for GA have also been described, although there remains a paucity of randomized controlled studies. In this review, we summarize recent updates on GA epidemiology and etiopathogenesis and offer an updated review of the therapeutic options for GA currently reported in the literature. We hope that the current review galvanizes randomized controlled studies that will in turn help lead to the recommendation of evidence-based treatments for GA.